Service Configures Ready-Made Solution for Randomization and Trial Supply Management
Service Configures Ready-Made Solution for Randomization and Trial Supply Management
ClinPhone (Nottingham, UK) announces its ClinPhone Compact, a new service created to meet the needs of many conventional study designs by offering a ready-made application for Interactive Voice Response and Interactive Web Response deployment.
eShowcase: ClinPhone Compact
The new service is hosted by ClinPhone and utilizes its existing infrastructure offerings of 24/7 global support, unlimited language capabilities, and an extensive toll-free network of 82 countries.
ClinPhone Compact allows pharmaceutical and biotechnology sponsors to perform central randomization, emergency code break, medication dispensation, and site and depot supplies management combined with real-time study progress reporting. Because the solution is ready-made, it minimizes the need for study-specific customization, including programming, testing, and validation. As such, this can lower sponsors' costs and accelerate timelines.
ClinPhone plc, +44 (0)115 9557555, www.clinphone.com
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
July 31st 2025In this pilot episode of the Applied Clinical Trials Brief, we examine the renewed push for placebo-controlled vaccine trials in the US, why experts warn it violates core ethical standards, and how these proposals could jeopardize both participant safety and future innovation.
Cardiff Reports 49% Response Rate With Onvansertib in RAS-Mutated Colorectal Cancer
July 31st 2025In the ongoing Phase II CRDF-004 trial, onvansertib plus standard-of-care showed a 49% confirmed ORR and early PFS benefit in first-line RAS-mutated metastatic colorectal cancer, with a favorable safety profile and dose-dependent efficacy across endpoints.
Unifying Industry to Better Understand GCP Guidance
July 31st 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.